87 related articles for article (PubMed ID: 2668834)
1. A dialysable acid factor from human leukocyte extracts activates tumor cell lysis mediated by human monocytes and natural killer cells.
Hamprecht KH; Vötsch W; Anderer FA
Onkologie; 1989 Jun; 12(3):120-7. PubMed ID: 2668834
[TBL] [Abstract][Full Text] [Related]
2. Activation of human monocyte and natural killer cell-mediated tumour cell killing by two dialysable thymic factors.
Hamprecht K; Vötsch W; Anderer FA
Scand J Immunol; 1986 Jul; 24(1):59-71. PubMed ID: 3726459
[TBL] [Abstract][Full Text] [Related]
3. Dialysable factors from human leukocyte extracts activating human NK cytotoxicity against tumor cells: identification of factor-producing leukocyte subpopulations.
Neidlinger AC; Anderer FA
Anticancer Res; 1991; 11(6):2023-8. PubMed ID: 1776835
[TBL] [Abstract][Full Text] [Related]
4. Activation of antitumor cytotoxicity of human blood mononuclear cells by a basic factor from dialysable human-leukocyte extract.
Doelker I; Voetsch W; Anderer FA
Anticancer Res; 1989; 9(6):1915-20. PubMed ID: 2627139
[TBL] [Abstract][Full Text] [Related]
5. The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.
Doelker I; Anderer FA
Cancer Immunol Immunother; 1992; 34(5):299-305. PubMed ID: 1540976
[TBL] [Abstract][Full Text] [Related]
6. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
8. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
Itoh K; Platsoucas CD; Balch CM
Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
[TBL] [Abstract][Full Text] [Related]
9. Activation of natural killer cell cytotoxicity of human blood monocytes by a low molecular weight component from viscum album extract.
Klett CY; Anderer FA
Arzneimittelforschung; 1989 Dec; 39(12):1580-5. PubMed ID: 2624609
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
11. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
13. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
14. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
[TBL] [Abstract][Full Text] [Related]
15. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
Procopio AD; Allavena P; Ortaldo JR
J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
Wright SC; Wilbur SM; Bonavida B
Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous cytotoxicity by monocyte-enriched subpopulations of human peripheral blood mononuclear cells against human or mouse anchorage-dependent tumour cell lines. Contribution of NK-like cells.
Chang ZL; Hoffman T; Bonvini E; Stevenson HC; Herberman RB
Scand J Immunol; 1983 Nov; 18(5):439-49. PubMed ID: 6648367
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
[TBL] [Abstract][Full Text] [Related]
19. Tumor-activated NK cells trigger monocyte oxidative metabolism.
Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
[TBL] [Abstract][Full Text] [Related]
20. Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells.
Miltenburg AM; Meijer-Paape ME; Daha MR; Paul LC
Immunology; 1988 Sep; 65(1):107-12. PubMed ID: 3263311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
